DK1385497T3 - Forebyggelse eller behandling af bryst-, prostata- og/eller halscancer med N,N-dimethylglycin - Google Patents

Forebyggelse eller behandling af bryst-, prostata- og/eller halscancer med N,N-dimethylglycin

Info

Publication number: DK1385497T3
Authority: DK; Denmark
Prior art keywords: dimethylglycine; breast; prostate; prevention; treatment
Prior art date: 2001-04-20

Application number

DK02764251T

Other languages

English (en)

Inventor

Roger V Kendall

Original Assignee

Foodscience Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-20

Filing date

2002-04-19

Publication date

2006-07-17

2002-04-19 Application filed by Foodscience Corp filed Critical Foodscience Corp

2006-07-17 Application granted granted Critical

2006-07-17 Publication of DK1385497T3 publication Critical patent/DK1385497T3/da

Links

FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 title abstract 4
206010006187 Breast cancer Diseases 0.000 title abstract 2
208000026310 Breast neoplasm Diseases 0.000 title abstract 2
206010060862 Prostate cancer Diseases 0.000 title abstract 2
208000000236 Prostatic Neoplasms Diseases 0.000 title abstract 2
210000000481 breast Anatomy 0.000 title abstract 2
108700003601 dimethylglycine Proteins 0.000 title abstract 2
229940078490 n,n-dimethylglycine Drugs 0.000 title abstract 2
206010043515 Throat cancer Diseases 0.000 title 1
230000002265 prevention Effects 0.000 title 1
210000002307 prostate Anatomy 0.000 title 1
206010008342 Cervix carcinoma Diseases 0.000 abstract 1
206010027476 Metastases Diseases 0.000 abstract 1
208000006105 Uterine Cervical Neoplasms Diseases 0.000 abstract 1
201000010881 cervical cancer Diseases 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
230000009401 metastasis Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Oncology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK02764251T 2001-04-20 2002-04-19 Forebyggelse eller behandling af bryst-, prostata- og/eller halscancer med N,N-dimethylglycin DK1385497T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US83857101A	2001-04-20	2001-04-20

Publications (1)

Publication Number	Publication Date
DK1385497T3 true DK1385497T3 (da)	2006-07-17

Family

ID=25277454

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK02764251T DK1385497T3 (da)	2001-04-20	2002-04-19	Forebyggelse eller behandling af bryst-, prostata- og/eller halscancer med N,N-dimethylglycin

Country Status (6)

Country	Link
EP (1)	EP1385497B1 (da)
AT (1)	ATE319443T1 (da)
CA (1)	CA2444745A1 (da)
DE (1)	DE60209757T2 (da)
DK (1)	DK1385497T3 (da)
WO (1)	WO2002085345A1 (da)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4385068A (en) *	1980-03-10	1983-05-24	Davinci Laboratories, A Division Of Food Science Corporation	N,N-Dimethylglycine and use in immune response
US4994492A (en) *	1989-01-09	1991-02-19	Foodscience Corporation	Treatment of melanoma using N,N-dimethylglycine
US5026728A (en) *	1989-10-05	1991-06-25	Foodscience Corporation	Treatment of arthritis and inflammation using N,N-dimethylglycine

2002
- 2002-04-19 EP EP02764251A patent/EP1385497B1/en not_active Expired - Lifetime
- 2002-04-19 WO PCT/US2002/012425 patent/WO2002085345A1/en not_active Application Discontinuation
- 2002-04-19 CA CA002444745A patent/CA2444745A1/en not_active Abandoned
- 2002-04-19 DE DE60209757T patent/DE60209757T2/de not_active Expired - Fee Related
- 2002-04-19 DK DK02764251T patent/DK1385497T3/da active
- 2002-04-19 AT AT02764251T patent/ATE319443T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1385497A4 (en)	2005-06-08
WO2002085345A1 (en)	2002-10-31
EP1385497B1 (en)	2006-03-08
DE60209757T2 (de)	2006-11-23
EP1385497A1 (en)	2004-02-04
DE60209757D1 (de)	2006-05-04
CA2444745A1 (en)	2002-10-31
ATE319443T1 (de)	2006-03-15

Similar Documents

Publication	Publication Date	Title
DK1169059T3 (da)	2006-02-27	Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
DK1401438T3 (da)	2006-02-13	Anvendelse af cyclopamin i behandlingen af basalt cellecarcinom og andre tumorer
DK1373215T3 (da)	2006-11-13	Gelanamycinderivater egnet til behandling af cancer
WO2002005791A3 (en)	2003-01-03	Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor
ATE408601T1 (de)	2008-10-15	Fredericamycin-derivate
HK1082203A1 (en)	2006-06-02	Treatment and prevention of excessive scarring with 4-hydroxy tamoxifen
NO20032027D0 (no)	2003-05-06	Effektive antitumorbehandlinger
MY146533A (en)	2012-08-15	Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
GB0130677D0 (en)	2002-02-06	Medicaments and novel compounds
UA72927C2 (uk)	2005-05-16	Композиція для лікування печінково-клітинного раку, що містить доцетаксель
GB0020504D0 (en)	2000-10-11	Therapeutic method
DK1610864T3 (da)	2010-03-22	Elektromagnetisk stimulering af patienter med osteoporose
AR025718A1 (es)	2002-12-11	Metodo para reducir el riesgo de cancer
PL357179A1 (en)	2004-07-26	Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
DK1385497T3 (da)	2006-07-17	Forebyggelse eller behandling af bryst-, prostata- og/eller halscancer med N,N-dimethylglycin
PT1056458E (pt)	2005-08-31	Tratamento de dor cronica
WO2003045428A3 (de)	2003-12-18	Verwendung einer technisch veränderten zelle als vakzine zur behandlung einer tumorerkrankung
EA200601853A1 (ru)	2007-02-27	Лечение нарушенной дыхательной функции
SE0101258D0 (sv)	2001-04-06	Treatment of low back pain and whiplash associated disorder
DE60222662D1 (de)	2007-11-08	Verwendung von l-azetylcarnitin zur herstellung eines medikaments zur präventiven post-chirurgischen schmerzbehandlung
MXPA03010920A (es)	2004-02-27	Uso de alconil l- carnitina para preparacion de medicamento para tratar anhedonia.
NO20043774L (no)	2005-01-06	The use of devazenide as analgesic agent
UA32720A (uk)	2001-02-15	Спосіб внутрішнього відведення лімфи при мастектомії
AU2002307428A1 (en)	2002-11-05	Method of preventing or treating breast, prostate and/or cervical cancer with n,n-dimethylglycine
UA40393A (uk)	2001-07-16	Спосіб лікування хронічного обструктивного бронхіту